ATC Group: L03AA13 Pegfilgrastim

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of L03AA13 in the ATC hierarchy

Level Code Title
1 L Antineoplastic and immunomodulating agents
2 L03 Immunostimulants
3 L03A Immunostimulants
4 L03AA Colony stimulating factors
5 L03AA13 Pegfilgrastim

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
PAREN - Parenteral 0.3 mg

Active ingredients in L03AA13

Active Ingredient Description
Pegfilgrastim

Pegfilgrastim is a sustained duration form of filgrastim due to decreased renal clearance. Pegfilgrastim and filgrastim have been shown to have identical modes of action, causing a marked increase in peripheral blood neutrophil counts within 24 hours, with minor increases in monocytes and/or lymphocytes.

Related product monographs

Title Information Source Document Type  
FULPHILA Solution for injection European Medicines Agency (EU) MPI, EU: SmPC
NEULASTIM Solution for injection Health Products Regulatory Authority (ZA) MPI, Generic
NYVEPRIA Solution for injection European Medicines Agency (EU) MPI, EU: SmPC
PELMEG Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
STIMUFEND Solution for injection European Medicines Agency (EU) MPI, EU: SmPC
UDENYCA Solution for injection European Medicines Agency (EU) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Brazil (BR)

Cyprus (CY)

Hong Kong (HK)

Japan (JP)

Netherlands (NL)

New Zealand (NZ)

Singapore (SG)

South Africa (ZA)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.